Newsroom

Verified developments translated with care

Consortium announcements, evidence reviews and Asia-Pacific field notes.

Featured update
Evidence reviews

Interpretation of the World's First Official Compliance Standard for Longevity Medicine Clinics An Authoritative Guide to the Department of Health – Abu Dhabi (DoH) Healthy Longevity Medicine Clinic Standard with Asia-Pacific Practice Recommendations

The TASCAP Academic Committee interprets the world's first official standard for longevity medicine clinics, issued by Abu Dhabi's Department of Health in October 2024 and effective April 2025, covering MDT qualifications, the three-tier classification of diagnostics and interventions, and copyright attribution.

2026-08-07 · 8 minRead full article
01

Consortium updates

Public updates on TASCAP programmes, governance and opportunities to participate.

2026-05-06 · 5 min

TASCAP Targeted and Precision Anti-Aging Working Framework

A transparent pathway connecting baseline evidence targeted action regional delivery and longitudinal learning

Read full article
2026-04-22 · 4 min

Asia-Pacific Scientific Collaboration and Participation

How qualified researchers clinicians and institutions can contribute to evidence review standards and responsible translation

Read full article
02

Evidence reviews

Source-linked interpretation that keeps study design, maturity and limitations visible.

2026-08-07 · 8 min

Interpretation of the World's First Official Compliance Standard for Longevity Medicine Clinics An Authoritative Guide to the Department of Health – Abu Dhabi (DoH) Healthy Longevity Medicine Clinic Standard with Asia-Pacific Practice Recommendations

The TASCAP Academic Committee interprets the world's first official standard for longevity medicine clinics, issued by Abu Dhabi's Department of Health in October 2024 and effective April 2025, covering MDT qualifications, the three-tier classification of diagnostics and interventions, and copyright attribution.

Read full article
2026-08-07 · 7 min

Interpretation of China's Group Standard Clinical Testing Guidelines for Anti-Aging Medicine An Evidence-Based Tiered Framework Based on T/FDSA and Biological Age Assessment

An interpretation of the Clinical Testing Guidelines for Anti-Aging Medicine, drafted by Beijing Geriatric Hospital and governed by T/FDSA, covering the AgeDev age-deviation formula, a three-tier (strong / conditional / emerging) testing map, and quality control specifications.

Read full article
03

Asia-Pacific observations

Regional capabilities, terminology and implementation questions across Asia Pacific.

2026-04-08 · 6 min

Four Complementary Asia-Pacific Capabilities

Australia China Japan and Singapore contribute different strengths to a connected precision-longevity ecosystem

Read full article
2026-03-26 · 6 min

Designing Cross-Border Longitudinal Healthy-Aging Care

Why consented records wearable context and defined re-testing matter before and after regional service delivery

Read full article